About Agios (AGIO)
Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more
- USD28.14
- USD28.77
- USD27.72
- USD62.58
- 9.00%
- 37M
- 120.00
- 535.43k
- 1.7B
- 23.42
- -14.00%
Stock News
4 hours ago
Rivian: Near-Term Deliveries Cut Has No Bearing On R2's Future
SeekingAlpha
4 hours ago
Rates Spark: Market Discount Shifts To Un-Discounting Some Recession Risks
SeekingAlpha
5 hours ago
Uber: Accelerates AV Ambitions As Growth Shows Signs Of Stalling
SeekingAlpha
5 hours ago
The Next Frontier In Portfolio Design: Keeping Equities While Adding Gold
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
